Isis Pharmaceuticals Inc - Net Worth and Insider Trading
Isis Pharmaceuticals Inc Net Worth
The estimated net worth of Isis Pharmaceuticals Inc is at least $1.8 Billion dollars as of 2024-04-28. Isis Pharmaceuticals Inc is the 10% Owner of Akcea Therapeutics Inc and owns about 98,322,397 shares of Akcea Therapeutics Inc (AKCA) stock worth over $1.8 Billion. Isis Pharmaceuticals Inc is also the 10% Owner of Regulus Therapeutics Inc and owns about 43,110 shares of Regulus Therapeutics Inc (RGLS) stock worth over $104,326. Details can be seen in Isis Pharmaceuticals Inc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Isis Pharmaceuticals Inc has not made any transactions after 2020-10-10 and currently still holds the listed stock(s).
Transaction Summary of Isis Pharmaceuticals Inc
Isis Pharmaceuticals Inc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Isis Pharmaceuticals Inc owns 2 companies in total, including Akcea Therapeutics Inc (AKCA) , and Regulus Therapeutics Inc (RGLS) .
Click here to see the complete history of Isis Pharmaceuticals Inc’s form 4 insider trades.
Insider Ownership Summary of Isis Pharmaceuticals Inc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKCA | Akcea Therapeutics Inc | 2020-10-10 | 10 percent owner |
| RGLS | Regulus Therapeutics Inc | 2015-07-17 | 10 percent owner |
Isis Pharmaceuticals Inc Latest Holdings Summary
Isis Pharmaceuticals Inc currently owns a total of 2 stocks. Among these stocks, Isis Pharmaceuticals Inc owns 98,322,397 shares of Akcea Therapeutics Inc (AKCA) as of October 10, 2020, with a value of $1.8 Billion and a weighting of 99.99%. Isis Pharmaceuticals Inc also owns 43,110 shares of Regulus Therapeutics Inc (RGLS) as of July 17, 2015, with a value of $104,326 and a weighting of 0.01%.
Latest Holdings of Isis Pharmaceuticals Inc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKCA | Akcea Therapeutics Inc | 2020-10-10 | 98,322,397 | 18.17 | 1,786,517,953 |
| RGLS | Regulus Therapeutics Inc | 2015-07-17 | 43,110 | 2.42 | 104,326 |
Holding Weightings of Isis Pharmaceuticals Inc
Isis Pharmaceuticals Inc Form 4 Trading Tracker
According to the SEC Form 4 filings, Isis Pharmaceuticals Inc has made a total of 1 transactions in Akcea Therapeutics Inc (AKCA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Akcea Therapeutics Inc is the acquisition of 21,237,715 shares on October 10, 2020, which cost Isis Pharmaceuticals Inc around $385 Million.
According to the SEC Form 4 filings, Isis Pharmaceuticals Inc has made a total of 0 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years. The most-recent trade in Regulus Therapeutics Inc is the sale of 2,859 shares on July 17, 2015, which brought Isis Pharmaceuticals Inc around $4 Million.
Insider Trading History of Isis Pharmaceuticals Inc
- 1
Isis Pharmaceuticals Inc Trading Performance
GuruFocus tracks the stock performance after each of Isis Pharmaceuticals Inc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Isis Pharmaceuticals Inc is 42.19%. GuruFocus also compares Isis Pharmaceuticals Inc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Isis Pharmaceuticals Inc within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Isis Pharmaceuticals Inc's insider trading performs compared to the benchmark.
Performance of Isis Pharmaceuticals Inc
Average Return
101.23%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.68 | 42.19 | 41.27 | 101.23 | 15.83 | 11.65 |
| Relative Return to S&P 500(%) | 15.39 | 38.81 | 31.86 | 88.34 | 6.46 | 1 |
Isis Pharmaceuticals Inc Ownership Network
Ownership Network List of Isis Pharmaceuticals Inc
Ownership Network Relation of Isis Pharmaceuticals Inc
Isis Pharmaceuticals Inc Owned Company Details
What does Akcea Therapeutics Inc do?
Who are the key executives at Akcea Therapeutics Inc?
Isis Pharmaceuticals Inc is the 10 percent owner of Akcea Therapeutics Inc. Other key executives at Akcea Therapeutics Inc include director & Chief Executive Officer Damien Mcdevitt , Chief Medical Officer William T. Andrews , and Chief Financial Officer Michael Dennis Price .
Akcea Therapeutics Inc (AKCA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Akcea Therapeutics Inc (AKCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akcea Therapeutics Inc (AKCA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Akcea Therapeutics Inc (AKCA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akcea Therapeutics Inc Insider Transactions
Isis Pharmaceuticals Inc Mailing Address
Above is the net worth, insider trading, and ownership report for Isis Pharmaceuticals Inc. You might contact Isis Pharmaceuticals Inc via mailing address: 2855 Gazelle Court, Carlsbad Ca 92010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
